Table 2. Self-reported experience of comorbidities between unmatched ASRS-negative control group and ASRS-positive groups, between matched ASRS-A-negative and ASRS-A+ (score ≥4 for Part A), and between matched ASRS-AB-negative and ASRS-AB+ (score ≥9 for both Parts A and B).
Prior matching | Matched ASRS-A- versus ASRS-A+ | Matched ASRS-AB- versus ASRS-AB+ | ||||||||
ASRS negative (N = 9,280) | Matched ASRS-A- (N = 1,236) | ASRS-A+ (N=309) | Matched ASRS-AB- (N = 908) | ASRS-AB+ (N = 227) | ||||||
Mental and neurological disorders | Count | % | Count | % | Count | % | Count | % | Count | % |
Anxiety | 1,328 | 14.31% | 234 | 18.93% | 119 | 38.51%ab | 179 | 19.71% | 80 | 35.24%ac |
Depression | 295 | 3.18% | 53 | 4.29% | 65 | 21.04%ab | 38 | 4.19% | 56 | 24.67%ac |
Generalized anxiety disorder | 33 | 0.36% | 5 | 0.40% | 15 | 4.85%ab | 2 | 0.22% | 16 | 7.05%ac |
Obsessive-compulsive disorder | 43 | 0.46% | 12 | 0.97% | 10 | 3.24%ab | 6 | 0.66% | 10 | 4.41%ac |
Panic disorder | 99 | 1.07% | 16 | 1.29% | 19 | 6.15%ab | 18 | 1.98% | 16 | 7.05%ac |
Phobias | 51 | 0.55% | 14 | 1.13% | 19 | 6.15%ab | 11 | 1.21% | 16 | 7.05%ac |
Post-traumatic stress disorder | 45 | 0.48% | 7 | 0.57% | 9 | 2.91%ab | 6 | 0.66% | 6 | 2.64%ac |
Social anxiety disorder | 97 | 1.05% | 25 | 2.02% | 36 | 11.65%ab | 14 | 1.54% | 27 | 11.89%ac |
Schizophrenia | 75 | 0.81% | 17 | 1.38% | 21 | 6.80%ab | 11 | 1.21% | 18 | 7.93%ac |
Bipolar disorder | 45 | 0.48% | 10 | 0.81% | 18 | 5.83%ab | 4 | 0.44% | 16 | 7.05%ac |
Sleep problems | Count | % | Count | % | Count | % | Count | % | Count | % |
Insomnia | 637 | 6.86% | 96 | 7.77% | 87 | 28.16%ab | 78 | 8.59% | 63 | 27.75%ac |
Narcolepsy | 21 | 0.23% | 4 | 0.32% | 5 | 1.62%ab | 6 | 0.66% | 5 | 2.20%ac |
Sleep apnea | 249 | 2.68% | 32 | 2.59% | 24 | 7.77%ab | 18 | 1.98% | 12 | 5.29%ac |
Sleep difficulties (other than insomnia, narcolepsy or sleep apnea) | 99 | 1.07% | 19 | 1.54% | 16 | 5.18%ab | 21 | 2.31% | 16 | 7.05%ac |
Physical conditions | Count | % | Count | % | Count | % | Count | % | Count | % |
Allergies | 951 | 10.25% | 144 | 11.65% | 58 | 18.77%ab | 115 | 12.67% | 51 | 22.47%ac |
Asthma | 297 | 3.20% | 41 | 3.32% | 26 | 8.41%ab | 32 | 3.52% | 23 | 10.13%ac |
Chronic obstructive pulmonary disease | 32 | 0.34% | 4 | 0.32% | 3 | 0.97% | 2 | 0.22% | 4 | 1.76%ac |
High cholesterol | 1,114 | 12.00% | 113 | 9.14% | 37 | 11.97% | 69 | 7.60% | 26 | 11.45% |
Type 2 diabetes mellitus | 379 | 4.08% | 55 | 4.45% | 14 | 4.53% | 35 | 3.85% | 13 | 5.73% |
Obesity | 1,651 | 17.79% | 270 | 21.84% | 71 | 22.98%a | 198 | 21.81% | 49 | 21.59% |
Hypertension | 1,370 | 14.76% | 140 | 11.33% | 36 | 11.65% | 72 | 7.93% | 28 | 12.33%c |
Alcoholism | 58 | 0.63% | 1 | 0.08% | 9 | 2.91%ab | 5 | 0.55% | 5 | 2.20%ac |
Non-alcoholic steatohepatitis | 43 | 0.46% | 4 | 0.32% | 6 | 1.94%ab | 6 | 0.66% | 5 | 2.20%ac |